The swiping of the pandemic’s three-yearslong designation as a “public health emergency of international concern” comes after confirmed global cases have been on a steep decline since December.
“While acknowledging the remaining uncertainties posted by potential evolution of SARS-CoV-2, [the committee] advised that it is time to transition to long-term management of the COVID-19 pandemic,” the WHO release said.
In the U.S., the death rate from all causes has dropped 5.3 percent, and COVID-19 related deaths have dropped 47 percent between 2021 and 2022. Heart disease and cancer remain the top two causes of death, while unintentional injury — which includes drug overdoses and car crashes — has returned to the third leading cause.
In 2022, heart disease was responsible for 699,659 deaths; cancer for 607,790 deaths; unintentional injury for 218,064 deaths; and COVID-19 for 186,702 deaths.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
